澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

ALGORAE PHARMACEUTICALS LTD

0.018

0.000

成交量：147.49万

成交额：2.63万

市值：3,039.77万

市盈率：-36.07

高：0.019

开：0.019

低：0.017

收：0.018

52周最高：0.024

52周最低：0.005

股本：16.89亿

流通股本：10.47亿

量比：1.55

换手率：0.14%

股息：- -

股息率：- -

每股收益(TTM):0.000

每股收益(LYR):0.000

净资产收益率：-30.63%

总资产收益率：-23.85%

市净率：13.64

市盈率(LYR):-36.07

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Algorae制药公司达成协议将在澳大利亚和新西兰推出两款心血管及代谢疾病仿制药

Algorae Pharmaceuticals - 签署协议向澳大利亚市场供应化疗药物卡培他滨

Algorae Pharmaceuticals - 拟议协议下，公司将在澳新市场推出两款仿制药及其他产品

Algorae Pharmaceuticals达成协议，将5款仿制肿瘤药物推向澳大利亚和新西兰市场

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/1AI.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"1AI.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AI.AU\",,,,,undefined,":{"symbol":"1AI.AU","market":"AU","secType":"STK","nameCN":"ALGORAE PHARMACEUTICALS LTD","latestPrice":0.018,"timestamp":1771477920000,"preClose":0.018,"halted":0,"volume":1474915,"delay":0,"changeRate":0,"nameEN":"ALGORAE PHARMACEUTICALS LTD","floatShares":1046585658,"shares":1688759058,"eps":-0.000499,"marketStatus":"未开盘","change":0,"latestTime":"02-19 16:12:00 AEDT","open":0.019,"high":0.019,"low":0.017,"amount":26344,"amplitude":0.111111,"askPrice":0.019,"askSize":483463,"bidPrice":0.017,"bidSize":2278246,"shortable":3,"etf":0,"ttmEps":-0.000499,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1771542000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.018,"openAndCloseTimeList":[[1771455600000,1771477200000]],"volumeRatio":1.5457282097030716,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AI.AU\",,,,,undefined,":{"symbol":"1AI.AU","floatShares":1046585658,"roa":"-23.85%","roe":"-30.63%","lyrEps":-0.000499,"volumeRatio":1.5457282097030716,"shares":1688759058,"dividePrice":0,"high":0.019,"amplitude":0.111111,"preClose":0.018,"low":0.017,"week52Low":0.005,"pbRate":"13.64","psRate":"215.51","week52High":0.024,"institutionHeld":0,"latestPrice":0.018,"committee":0.649881,"eps":-0.000499,"divideRate":0,"volume":1474915,"delay":0,"ttmEps":-0.000499,"open":0.019,"prevYearClose":0.014,"prevWeekClose":0.02,"prevMonthClose":0.021,"prevQuarterClose":0.014,"fiveDayClose":0.021,"twentyDayClose":0.02,"sixtyDayClose":0.012,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AI.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AI.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"1AI.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199700351","title":"Algorae制药公司达成协议 将在澳大利亚和新西兰推出两款心血管及代谢疾病仿制药","url":"https://stock-news.laohu8.com/highlight/detail?id=1199700351","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199700351?lang=zh_cn&edition=fundamental","pubTime":"2026-02-09 06:04","pubTimestamp":1770588254,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals Ltd宣布已签署一项重要合作协议，计划在澳大利亚与新西兰市场同步上市两款针对心血管疾病和代谢紊乱的通用名药物。\n此次战略布局将显著提升该公司在大洋洲医药市场的竞争力，通过提供高性价比的替代治疗方案，有望缓解当地患者长期用药的经济压力。两款药物的上市也将进一步完善Algorae在慢性病治疗领域的产品矩阵。\n业内人士分析，此次合作将加速仿制药在澳新地区的市场渗透，为Algorae拓展亚太区域业务奠定坚实基础。随着人口老龄化趋势加剧，心血管与代谢疾病药物市场需求持续增长，此举契合区域医疗健康产业的发展方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"1125866279","title":"Algorae Pharmaceuticals - 签署协议向澳大利亚市场供应化疗药物卡培他滨","url":"https://stock-news.laohu8.com/highlight/detail?id=1125866279","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125866279?lang=zh_cn&edition=fundamental","pubTime":"2025-11-27 06:01","pubTimestamp":1764194483,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals - 签署协议向澳大利亚市场供应化疗药物卡培他滨","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"1150849384","title":"Algorae Pharmaceuticals - 拟议协议下，公司将在澳新市场推出两款仿制药及其他产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1150849384","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150849384?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 06:01","pubTimestamp":1760911268,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals - 拟议协议下，公司将在澳新市场推出两款仿制药及其他产品","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"1163905870","title":"Algorae Pharmaceuticals达成协议，将5款仿制肿瘤药物推向澳大利亚和新西兰市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1163905870","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163905870?lang=zh_cn&edition=fundamental","pubTime":"2025-09-23 06:55","pubTimestamp":1758581719,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals达成协议，将5款仿制肿瘤药物推向澳大利亚和新西兰市场","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/1AI.AU\",params:#limit:6,delay:true,,,undefined,":[]}}